Angelo Cabal
Impact in
Papers in
- Oncology 6
- PARP inhibition in cancer therapy 3
- Pancreatic and Hepatic Oncology Research 2
- Cancer Immunotherapy and Biomarkers 2
-
- Prostate Cancer Treatment and Research 3
- Infection Control and Ventilation 1
- Co-authors
- George Kritikos (1 shared paper)Jeremiah D. Farelli (1 shared paper)David Z. Rudner (1 shared paper)Marco Galardini (1 shared paper)Byoung‐Mo Koo (1 shared paper)Anna‐Barbara Hachmann (1 shared paper)Karen N. Allen (1 shared paper)Athanasios Typas (1 shared paper)
- Journals
- Clinical Genitourinary Cancer (3 papers)Journal of Clinical Oncology (2 papers)Cancer Medicine (2 papers)Cell Systems (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Angelo Cabal
9 papers receiving 482 citations
Angelo Cabal's Hit Papers
Peers
Comparison fields: 5 of 78
- Genetics 240
- Ecology 145
- Molecular Biology 342
- Molecular Medicine 24
- Endocrinology 20
Countries citing papers authored by Angelo Cabal
This map shows the geographic impact of Angelo Cabal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Cabal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Cabal more than expected).
Fields of papers citing papers by Angelo Cabal
This network shows the impact of papers produced by Angelo Cabal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Cabal. The network helps show where Angelo Cabal may publish in the future.
Co-authors
The 25 scholars most cited alongside Angelo Cabal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Construction and Analysis of Two Genome-Scale Deletion Libraries for Bacillus subtilis Hit paper breakdown → | 2017 | 414 |
| 2 | 2014 | 24 | |
| 3 | 2022 | 15 | |
| 4 | 2021 | 10 | |
| 5 | 2021 | 7 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 4 | |
| 8 | 2024 | 3 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 0 |
About Angelo Cabal
Angelo Cabal is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Infectious Diseases, having authored 10 papers that have together received 483 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), PARP inhibition in cancer therapy (3 papers), Cancer Genomics and Diagnostics (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Infection Control and Ventilation (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Genetics (240 citations), Ecology (145 citations), Molecular Biology (342 citations), Molecular Medicine (24 citations) and Endocrinology (20 citations). Angelo Cabal has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include George Kritikos, Jeremiah D. Farelli, David Z. Rudner, Marco Galardini, Byoung‐Mo Koo, Anna‐Barbara Hachmann, Karen N. Allen, Athanasios Typas, Horia Todor and Carol A. Gross. Their work appears in journals such as Clinical Genitourinary Cancer, Journal of Clinical Oncology, Cancer Medicine, Cell Systems and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.